Ingenus was born in 2010, came to market in 2012 and we are continuously expanding our roster of high impact generic pharmaceutical products. We’ve built Ingenus on a foundation of innovation and collaboration to meet the unique needs of U.S. consumers. Our expansive generic product focus proves it.
With our team of over 140 developers and scientists, Ingenus today is poised to file 15- 25 ANDAs per year.
|
Name
|
Strength
|
NDC/SKU Numbers
|
Case Pack
|
TE Rating
|
Image
|
|---|---|---|---|---|---|
|
Betamethasone Valerate Foam
|
0.12%, 50 gm Topical Foam
|
50742-0315-50
|
12
|
AP
|
|
|
//
|
0.12%, 100 gm Topical Foam
|
50742-0315-01
|
12
|
AP
|
|
|
Clobetasol Propionate Foam
|
0.05%, 50 gm Topical Foam
|
50742-0304-50
|
12
|
AB1
|
|
|
//
|
0.05%, 100 gm Topical Foam
|
50742-0304-01
|
12
|
AB1
|
|
|
Mafenide Acetate Topical Solution
|
5% 50 gm Topical Solution
|
50742-0310-25
|
12
|
AT
|
|
|
Nitro-Dur® Transdermal Patches
|
0.1 mg, 30 Patches
|
50742-0513-30
|
24
|
None
|
|
|
//
|
0.2 mg, 30 Patches
|
50742-0514-30
|
24
|
None
|
|
|
//
|
0.3 mg, 30 Patches
|
50742-0515-30
|
24
|
None
|
|
|
//
|
0.4 mg, 30 Patches
|
50742-0516-30
|
24
|
None
|
|
|
//
|
0.6 mg, 30 Patches
|
50742-0517-30
|
24
|
None
|
|
|
//
|
0.8 mg, 30 Patches
|
50742-0518-30
|
24
|
None
|
|